Anesthesia and Respiratory Devices Market Size, Share, By Product Type (Anesthesia Devices, Respiratory Devices, Monitoring Devices, Diagnostic Devices, and Consumables and Accessories), Gender (Male and Female), End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Service Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

• The anesthesia and respiratory devices market size is anticipated to reach a valuation of USD 90.7 Billion by 2035.
• In 2024, the valuation of the market was USD 51.8 Billion
• The target market is projected to rise at a CAGR of 6.0%.

Anesthesia and respiratory devices are medical equipment used to administer anesthesia during surgery, including ventilators, masks, and airway management tools, allowing controlled breathing during the procedure. The rising aging population, rising prevalence of respiratory diseases, the increasing surgical procedures, and technological advancements are factors pitching the anesthesia and respiratory devices market growth. The anesthesia and respiratory devices help in providing precise control over airway management, minimize the risks of complications, conserve body heat and humidity, and enable safe and effective surgery across a variety of patient conditions, thus, further contributing to market diversification.

Impact of AI on the Anesthesia and Respiratory Devices Market:

Early detection and better management of various liver conditions, such as cirrhosis, hepatocellular carcinoma (HCC), and non-alcoholic fatty liver disease (NAFLD), are made possible by artificial intelligence (AI), which is having a significant impact on liver disease treatment. AI assists in drug discovery, improves diagnosis accuracy, predicts disease progression, and personalizes treatment plans. This is especially true when analyzing complex patient data sets and medical imaging.

Key Drivers of Target Market:

Rising Prevalence of Respiratory Devices is Driving the Market Expansion

The anesthesia and respiratory devices market is growing due to the increasing prevalence of respiratory diseases such as asthma and COPD. This is because the healthcare industry is producing and selling more specialized respiratory devices to manage these conditions; in other words, as more people require respiratory support, the market for devices that provide that support grows.

• For instance, in November 2024, according to an article published by WHO, each year, over 3 million lives are silently cut short by chronic obstructive pulmonary disease (COPD), a non-communicable respiratory disease often overlooked despite affecting over 380 million people globally. COPD, the world’s fourth leading cause of death, has been largely absent from conversations on global health, despite its devastating toll on patients and families.

Restraints:

Risks of Causing Device-Associated Infections are Obstructing the Market Growth

The danger of infections linked to anesthetic and respiratory equipment as a result of continuous usage and inadequate sanitation is a major obstacle in the market. Hospital-acquired illnesses and respiratory issues might result from contaminated equipment.  Furthermore, patient safety may be at risk due to mechanical malfunctions in vital equipment.

• Counterbalance Statements: Using automatic self-cleaning systems and sophisticated antimicrobial coatings can lower the danger of infection. Patient safety can be improved and equipment faults can be avoided with routine predictive maintenance with IoT sensors.

Opportunities:

Amalgamation of Advanced Technologies with Anesthesia and Respiratory Devices Opens Up Growth Opportunities in the coming years

The anesthesia and respiratory devices market can grow significantly due to advanced technologies such as artificial intelligence (AI), enhanced monitoring capabilities, miniaturization, and integration with electronic health records. These technologies allow for more accurate patient monitoring, individualized treatment plans, enhanced safety features, and greater accessibility across different healthcare settings, all of which improve patient outcomes and increase the use of these devices.

• For instance, in January 2025, VADI Medical debuted its latest innovations at MD&M West 2025. The company, known for its high-quality range of products including humidifiers, breathing circuits, bacterial filters, CPAP masks, anesthesia circuits, and resuscitators, showcased its next-generation smart humidification system and optimized breathing circuits. These next-generation systems aim to improve patient care and enhance operational efficiency for healthcare providers.

The anesthesia and respiratory devices market is classified into product type, gender, end user, and region.

Product Type

By product type, the market is sub-segmented into anesthesia devices, respiratory devices, monitoring devices, diagnostic devices, and consumables and accessories. The respiratory devices segment is dominating the anesthesia and respiratory devices market share. This is due to the high prevalence of respiratory devices globally, leading to a significant demand for devices such as ventilators, nebulizers, and oxygen concentrators.

• For instance, in January 2025, Inspira Technologies OXY B.H.N. Ltd. had announced that the Company was establishing a dedicated production line for a crucial component of its innovative respiratory support system, in collaboration with Zriha Medical Ltd. The collaboration involved the manufacture of a flow mechanism that would be integrated into Inspira's products for use in the extracorporeal circulation of blood during the oxygenation process.

Gender

According to gender, the market is bifurcated into male and female. Men have the leading anesthesia and respiratory devices market as men have a higher risk of respiratory issues such as asthma and chronic obstructive pulmonary disease. This is due to physiological traits such as narrower airways.

End-User

Under end-user, the market is pigeonholed into hospitals, clinics, home care settings, ambulatory service centers, and others. The hospitals segment is ruling over the market due to its advanced medical care, large-scale infrastructure,e and expertise to use advanced equipment, presence of experienced anesthetics and technicians, and comprehensive insurance coverage for in-patient procedures.

• For instance, in September 2023, Dräger launched its new Atlan anesthesia workstation family in the United States. The Atlan anesthesia workstation family could provide safe and precise intraoperative ventilation of surgical patients, from neonates to adults. The device was also equipped with a system of extensive safety functions, which helped to avoid unintentionally high tidal volumes or inspiratory pressures.

Region

Geographically, the market is branched into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This is the region that holds the largest anesthesia and respiratory devices market share at 42.4%. This is due to its advanced healthcare infrastructure, increasing number of surgical procedures, rising aging population, widespread adoption of advanced technology, rising medical tourism, favorable government policies, and high healthcare expenditure.

• For instance, in November 2024, North American Partners in Anesthesia (NAPA), announced the launch of NAPA Managed Services. This comprehensive client solution was designed to address critical operating room (OR) operational needs for health systems and academic medical centers (AMCs). The new offering allowed healthcare institutions to maintain autonomy over their anesthesia services while benefiting from NAPA's industry-leading expertise in revenue cycle management (RCM), data and analytics, consulting, recruitment, and operational excellence.

Asia Pacific: The market in this region grows with the highest growth rate during the forecast period. This is due to its rising aging population, rising prevalence of respiratory devices, increasing healthcare spending, rising chronic diseases, economic development, favorable government initiatives, and growing medical tourism.

• For instance, in November 2021, MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announced the regulatory clearance and marketing approval of its HFVI MOC-9, High-Frequency Variability Index monitor, in Japan. MDoloris’ HFVI MOC-9 Technology was the first monitoring solution for patients going through analgosedation and anesthesia in Japan.

Anesthesia and Respiratory Devices Market Report Scope:

Segmentation:

By Product Type:

• Anesthesia Devices
  • Anesthesia Delivery Machines
  • Anesthesia Disposables & Accessories
  • Anesthesia Monitors
  • Anesthesia Information Management Systems (AIMS)
  • Others
• Respiratory Devices
  • Therapeutic Devices
  • Masks
  • Ventilators
  • Nebulizers
  • Humidifiers
  • Oxygen Concentrators
  • Inhalers
  • Reusable Resuscitators
  • Nitric Oxide Delivery Units
  • Capnographs
  • Others
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Gender:

• Male
• Female

By End User:

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Service Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

The companies operating in the market are BD, Drägerwerk AG & Co. KGa, Fisher & Paykel Healthcare Limited, GE HealthCare, Medtronic, and others. The key players are adopting strategies such as developing innovative products, forging strategic partnerships, and engaging in collaborative ventures, and acquisitions for the diversification of the market.

Anesthesia and Respiratory Devices Market Companies:

• BD
• Drägerwerk AG & Co. KGa
• GE HealthCare
• Medtronic
• Koninklijke Philips N.V.
• Teleflex Incorporated
• Masimo
• Fisher & Paykel Healthcare Limited
• ICU Medical, Inc.
• ResMed
• Inogen, Inc.
• CAIRE Inc.
• Drive Devilbiss International
• Getinge

View an Additional List of Companies in the Anesthesia and Respiratory Devices Market

• In May 2022, Fisher & Paykel Healthcare Corporation Limited announced it had launched two new devices developed specifically for use in anesthesia applications. These applications expanded the market opportunity for Optiflow nasal high flow within the company’s hospital respiratory support segment. The company released the Optiflow Switch and Optiflow Trace nasal high-flow interfaces into selected markets following a number of years of research and development.
• In March 2023, BHV Partners launched a new startup, Conus Airway, to develop medical devices aimed at improving anesthesia and surgery of the respiratory tract. The startup would develop devices based on technology designed by the head of the pediatric thoracic surgery department at the University and Polytechnic La Fe Hospital of Valencia. These medical devices enabled endotracheal dilation and ventilation, reducing risks, improving results, minimizing cross-contamination, and increasing efficiency in respiratory tract surgery.

Analyst View:

Factors driving the growth of the anesthesia and respiratory devices market include the aging population, the incidence of respiratory disorders, the rise in surgical operations, and technological improvements.  Further contributing to market diversification are the anesthesia and respiratory devices, which help to provide precise control over airway management, reduce the risk of complications, conserve body heat and humidity, and enable safe and effective surgery across a range of patient conditions.

More Related Reports

Local Anesthesia Drugs Market
Anesthesia Carts Market
Anesthesia Devices Market
Inhalation Anesthesia Market
Respiratory Device Market